THIS STORY HAS BEEN FORMATTED FOR EASY PRINTING

Merck to buy N.H. biotech in record bid

Privately held GlycoFi to net $400m in cash

By Stephen Heuser
Globe Staff / May 10, 2006

E-mail this article

Invalid E-mail address
Invalid E-mail address

Sending your article

Your article has been sent.

Text size +

A small New Hampshire firm with a new idea for making biotechnology drugs said yesterday it would be acquired by global pharmaceutical giant Merck & Co. for $400 million in cash, the largest such deal ever reported for a private biotechnology company. (Full article: 469 words)

This article is available in our archives:

Globe Subscribers

FREE for subscribers

Subscribers to the Boston Globe get unlimited access to our archives.

Not a subscriber?

Non-Subscribers

Purchase an electronic copy of the full article. Learn More

  • $9.95 1 month archives pass
  • $24.95 3 months archives pass
  • $74.95 1 year archives pass